Successful management of enzyme replacement therapy in related fabry disease patients with severe adverse events by switching from agalsidase Beta (fabrazyme(®)) to agalsidase alfa (replagal (®)).
about
Successful management of enzyme replacement therapy in related fabry disease patients with severe adverse events by switching from agalsidase Beta (fabrazyme(®)) to agalsidase alfa (replagal (®)).
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Successful management of enzym ...... galsidase alfa (replagal (®)).
@ast
Successful management of enzym ...... galsidase alfa (replagal (®)).
@en
Successful management of enzym ...... switching from agalsidase Beta
@nl
type
label
Successful management of enzym ...... galsidase alfa (replagal (®)).
@ast
Successful management of enzym ...... galsidase alfa (replagal (®)).
@en
Successful management of enzym ...... switching from agalsidase Beta
@nl
prefLabel
Successful management of enzym ...... galsidase alfa (replagal (®)).
@ast
Successful management of enzym ...... galsidase alfa (replagal (®)).
@en
Successful management of enzym ...... switching from agalsidase Beta
@nl
P2093
P2860
P356
P1476
Successful management of enzym ...... galsidase alfa (replagal (®)).
@en
P2093
Fuji Somura
Hiromi Goto
Hiroshi Yamamoto
Kazuya Tsuboi
P2860
P304
P356
10.1007/8904_2014_304
P577
2014-04-10T00:00:00Z